Viewing Study NCT02165202


Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2026-02-25 @ 8:31 PM
Study NCT ID: NCT02165202
Status: COMPLETED
Last Update Posted: 2018-08-27
First Post: 2014-05-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis
Sponsor: PATH
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: HPTN 076
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None NIH View
None NIH View